MYO9B and type 1 diabetes mellitus: Since substantial evidence exists for comorbidity between intestinal disease-related gut permeability and T1D35,36, two human studies have been performed to evaluate the effects of MYO9B gene polymorphisms on T1D patients, focusing on the most studied SNPs Rs962917, Rs2279003, and Rs230576423,24.